Related Experiment Video
Updated: Jun 11, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia
Olaf Merkel1, Daniela Asslaber, Josefina D Piñón
1Laboratory for Immunological and Molecular Cancer Research, IIIrd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology of the Paracelsus Medical University Salzburg, Salzburg, Austria. o.merkel@salk.at
Abstract:
Chronic lymphocytic leukemia (CLL) has an incidence 4/1,00,000 people in the western world and is one of the first cancers reported to be associated with deregulated miRNA expression. microRNAs are small non coding RNAs that are important regulators of protein expression through binding to their untranslated 3'-UTR region. The miR-34 family was demonstrated to be induced by the tumor suppressor p53 and to elicit p53-like responses like senescence, cell cycle arrest and apoptosis depending on the cell type. We have shown in a recent paper that miR-34a is severely increased in the TCL1-mouse model of CLL. This finding was reflected in human CLL. Moreover, it is demonstrated that its expression is dependent on the presence of the SNP309 in the intronic promoter of the MDM2 gene. In addition, low miR-34a expression was associated with shorter time to treatment (log-rank p = 0.003) in CLL. When reintroduced into CLL cells, miR-34a was able to induce apoptosis. Interestingly, this was dependent on an intact p53 pathway. Here, we present data showing that knockdown of p53 in HCT-116 cells severely reduces miR-34a induced apoptosis. In conclusion, miR-34a is proposed as a marker for the activity of the p53 pathway in CLL.
Insights
MicroRNA-34a (miR-34a) is elevated in chronic lymphocytic leukemia (CLL) and linked to shorter treatment times. Its apoptosis-inducing effect in CLL cells depends on the p53 pathway.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Chronic lymphocytic leukemia (CLL) incidence is 4/100,000, with deregulated microRNA (miRNA) expression noted.
- MicroRNAs are small, non-coding RNAs regulating protein expression by targeting 3'-UTR regions.
- The miR-34 family, induced by p53, mediates tumor suppressor functions like apoptosis and cell cycle arrest.
Purpose of the Study:
- Investigate the role of miR-34a in CLL.
- Determine the relationship between miR-34a expression, SNP309, and treatment time in CLL.
- Assess the functional impact of miR-34a reintroduction and p53 pathway integrity in CLL cells.
Main Methods:
- Analysis of miR-34a expression in a TCL1-mouse model of CLL and human CLL samples.
- Correlation of miR-34a expression with SNP309 in the MDM2 gene promoter.
- Assessment of miR-34a's effect on apoptosis in CLL cells and p53-knockdown HCT-116 cells.
Main Results:
- miR-34a is significantly increased in both mouse and human CLL.
- miR-34a expression is linked to SNP309 and inversely correlated with time to treatment in CLL.
- Reintroduction of miR-34a induces apoptosis in CLL cells, dependent on an intact p53 pathway.
Conclusions:
- miR-34a is a key player in CLL pathogenesis.
- miR-34a expression levels and their dependence on p53 activity can serve as prognostic markers in CLL.
- miR-34a is proposed as a marker for p53 pathway activity in CLL.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
DNA Damage Can Stall the Cell Cycle
